Look for:

Products

Our offer for

Equity funds

Sporotrend

 
Equity fund suitable for those investors who believe in positive developments on the stock markets of the new member states and EU candidate countries in Central and Eastern European region. Invests in the Russian and Turkish markets.

Select your Criteria
Fund Company
Currency
Recommended holding period

Page 1 of 2
<<
<
>
>>

Equity Funds

Name  
ISIN
Investment
Company  
Product description  Recommended
holding period  
Currency  NAV
Date NAV
ERSTE EQUITY RESEARCH VT
AT0000A09VE4
Erste Asset Management GmbHGlobal equity fund focused on quality stocksAt least 6 yearsEUR28.6100
2024/07/16
ERSTE FUTURE INVEST VT
AT0000A2HRU3
Erste Asset Management GmbHGlobal equity fund, focusing on promising future trendsAt least 6 yearsCZK3,021.7500
2024/07/16
ERSTE RESPONSIBLE STOCK AMERICA VT
AT0000639463
Erste Asset Management GmbHSustainable equity fund North AmericaAt least 6 yearsCZK21,528.7100
2024/07/16
ERSTE RESPONSIBLE STOCK AMERICA VT
AT0000673371
Erste Asset Management GmbHSustainable equity fund North AmericaAt least 6 yearsUSD927.5700
2024/07/16
ERSTE RESPONSIBLE STOCK AMERICA VT
AT0000A0A1P0
Erste Asset Management GmbHSustainable equity fund North AmericaAt least 6 yearsEUR854.4200
2024/07/16
ERSTE RESPONSIBLE STOCK EUROPE VT
AT0000A0WM11
Erste Asset Management GmbHEuropean equities with a focus on sustainabilityAt least 6 yearsEUR228.6600
2024/07/16
ERSTE RESPONSIBLE STOCK EUROPE VT
AT0000A2QP89
Erste Asset Management GmbHEuropean equities with a focus on sustainabilityAt least 6 yearsCZK3,178.4300
2024/07/16
ERSTE RESPONSIBLE STOCK GLOBAL (CZK) VT
AT0000A1AW14
Erste Asset Management GmbHEquities worldwide emphasizing sustainabilityAt least 6 yearsCZK219.1500
2024/07/16
ERSTE RESPONSIBLE STOCK JAPAN VT
AT0000633292
Erste Asset Management GmbHJapanese equity fundAt least 6 yearsCZK3,815.8500
2024/07/16
ERSTE STOCK BIOTEC VT
AT0000673165
Erste Asset Management GmbHBiotechnology stocks with a focus on the US marketAt least 6 yearsEUR556.5200
2024/07/16
ERSTE STOCK BIOTEC VT
AT0000A0XYP0
Erste Asset Management GmbHBiotechnology stocks with a focus on the US marketAt least 6 yearsCZK14,129.0100
2024/07/16
ERSTE STOCK COMMODITIES VT
AT0000A1E119
Erste Asset Management GmbHCommodity stocks of developed marketsAt least 6 yearsCZK4,827.5800
2024/07/16
ERSTE STOCK EM GLOBAL VT
AT0000A00GK1
Erste Asset Management GmbHEquity fund with a focus on global emerging marketsAt least 6 yearsEUR254.0500
2024/07/16
ERSTE STOCK EM GLOBAL VT
AT0000A10QN3
Erste Asset Management GmbHEquity fund with a focus on global emerging marketsAt least 6 yearsCZK6,438.6400
2024/07/16
ERSTE STOCK EUROPE EMERGING VT
AT0000639471
Erste Asset Management GmbHEquity fund with a focus on the emerging markets of Central and Eastern EuropeAt least 6 yearsCZK2,030.3300
2024/07/16
ERSTE STOCK EUROPE EMERGING VT
AT0000673181
Erste Asset Management GmbHEquity fund with a focus on the emerging markets of Central and Eastern EuropeAt least 6 yearsEUR80.0000
2024/07/16
ERSTE STOCK GLOBAL VT
AT0000639497
Erste Asset Management GmbHGlobal equity fund with a focus on growth stocksAt least 6 yearsCZK5,278.0900
2024/07/16
ERSTE STOCK GLOBAL VT
AT0000673314
Erste Asset Management GmbHGlobal equity fund with a focus on growth stocksAt least 6 yearsEUR208.1100
2024/07/16
ERSTE STOCK ISTANBUL VT
AT0000494885
Erste Asset Management GmbHEquity fund with a focus on TurkeyAt least 8 yearsCZK12,454.4600
2024/07/16
ERSTE STOCK ISTANBUL VT
AT0000494893
Erste Asset Management GmbHEquity fund with a focus on TurkeyAt least 8 yearsEUR490.7300
2024/07/16



Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer